Evidence-led peptide reference
GHK-Cu research guide
Also known as: Copper tripeptide-1
Updated 10 October 2026 · Editorial standards
A naturally occurring copper-binding tripeptide studied in skin, matrix and wound biology.
Identity and context
What is GHK-Cu?
GHK is the three-amino-acid sequence glycyl-L-histidyl-L-lysine. It can bind copper to form the GHK-Cu complex, also called copper tripeptide-1 in cosmetic ingredient terminology. Small amounts occur naturally in human plasma and other biological fluids.
The peptide and the copper ion should be considered together: binding can affect copper availability, molecular interactions and experimental behaviour. Formulation and route also matter, so evidence from a topical cosmetic cannot automatically support claims about an injectable research vial.
Mechanism under investigation
How is GHK-Cu studied?
Experimental literature links GHK-Cu with fibroblast activity, extracellular-matrix remodelling, collagen and glycosaminoglycan production, antioxidant responses and signalling involved in wound repair. Proposed gene-expression effects are broad, but broad mechanistic activity is not the same as a clinically meaningful outcome.
Copper is biologically necessary but can also participate in oxidative chemistry. Identity, copper content, purity, formulation and contamination control are all relevant when interpreting a material.
Research map
Main areas of interest
Skin and matrix biology
Cell and tissue studies examine collagen, elastin-related processes, fibroblasts and extracellular-matrix organisation.
Wound models
Experimental models investigate cell migration, inflammatory signalling, angiogenesis and tissue remodelling.
Hair research
GHK-Cu appears in hair-follicle and cosmetic research, but product-specific controlled human evidence is limited.
Strength of evidence
What does the evidence actually show?
Evidence is separated by level because a cell experiment, an animal model, a human trial and a regulatory decision answer different questions.
Critical reading
Limitations and unanswered questions
- Topical, cell-culture and injectable evidence are not interchangeable.
- Cosmetic appearance endpoints do not establish treatment of disease.
- A measured total may include both peptide and copper; reports should state clearly what was quantified.
- Sterility, endotoxin and identity require different tests from a headline purity percentage.
Analytical context
What a certificate of analysis can—and cannot—tell you
A certificate of analysis is a report about the particular submitted sample and tests named on that report. It can help document identity, measured amount or purity when suitable methods were used. It does not prove that every batch is identical, that a material is sterile or endotoxin-free, that it is clinically effective, or that it is approved for human use.
Learn how to read a peptide COA →Questions answered
GHK-Cu FAQs
What does GHK-Cu stand for?
GHK refers to glycine-histidine-lysine; Cu indicates copper bound to the peptide.
Is copper tripeptide-1 the same name?
It is a common cosmetic ingredient name for the copper complex, though exact formulation and analytical identity still need checking.
Does topical evidence prove injectable effects?
No. Route, exposure and formulation are materially different, so evidence cannot simply be transferred.
What can a GHK-Cu COA show?
Depending on the methods, it may report identity, peptide content, copper content or purity. It does not automatically establish sterility, safety or clinical efficacy.
Primary and authoritative reading
Sources and further reading
Sources are provided so readers can inspect the underlying literature and current official information. Inclusion does not mean every claim in a paper has been independently confirmed.
- Cu-GHK fibroblast study ↗Primary in-vitro study of fibroblast activity and collagen production; formulation and experimental conditions matter.
- GHK topical evidence review ↗Recent peer-reviewed review indexed by PubMed.
- PubMed GHK-Cu literature ↗Broader indexed literature search for the copper complex.
Source and wording review: 7 October 2026. Prepared with AI assistance; no independent clinical review is claimed. Read the editorial policy or suggest a correction.